These recurrent mutations were identified in an independent melanoma WGS cohort (41), where 6 patient samples (3.3%) had RPL8; ENST00000262584:c.-94G>A and 1 patient sample had DCAF7; ENST00000310827:c.-207G>A. Here, RPL8 is linked to melanoma.